XCL2 and COVID-19: CD4 T-cells with cytotoxic activity (CD4 CTLs) and NK-cells displayed enhanced interferon signaling and effector activation markers (GZMB, GZMH, CCL4, XCL2) in patients who succumbed to COVID-19 (Supplementary Fig. 8d, e).